Besides, there was striking mutual exclusivity between RET and RAS mutations (including both HRAS and KRAS, Fisher’s exact test, P = 1.37e–08), corroborating their role as the most dominant drivers in sporadic MTC (Fig. 2a; Supplementary Table S3). This evidence concerns the gene HRAS and medullary thyroid gland carcinoma.